- Profile
- Personal Information
- Publications
Experts in Chemical Engineering
Prof. Amita Chaudhary Prof. Nikita Kaumil Shah Prof. Priya P Saxena Prof. Leena V. Bora Balakrishna Prabhu K Prof. Narasimha Reddy Ravuru Dr. Nimish R. Shah Dr. Parin D. Shah Dr. Milind H Joshipura Amit Goyal Eleni A. Kyriakidou GAO Lin SANDEEP GUPTA David A. Kofke Johannes Hachmann Gao Jinsen Liu Zhi Chang Chen Guangjin Lu Chunxi Liu Bei View MorePaul A. Friedman
Non-Executive Chairman
life sciencess
NSF Bioensaios
Finland
been a director of Alexion since September 2017. Dr. Friedman served as President and Chief Executive Officer of Incyte Corporation, a leading, publicly traded biopharmaceuticals company, from 2001-2014, where he led a transformation of the business from genomics to a therapeutic focus establishing its foundation as a leader in oncology. Currently, Dr. Friedman serves as Chairman and Chief Executive Officer of Madrigal Pharmaceuticals, Inc., following its merger with Synta Pharmaceuticals Corporation in July 2016. He has also held executive and R&D positions
been a director of Alexion since September 2017. Dr. Friedman served as President and Chief Executive Officer of Incyte Corporation, a leading, publicly traded biopharmaceuticals company, from 2001-2014, where he led a transformation of the business from genomics to a therapeutic focus establishing its foundation as a leader in oncology. Currently, Dr. Friedman serves as Chairman and Chief Executive Officer of Madrigal Pharmaceuticals, Inc., following its merger with Synta Pharmaceuticals Corporation in July 2016. He has also held executive and R&D positions